Drugs or disease: evaluating salivary function in RA patients
| Autor: | Carlos Henrique Silva Pedrazas, Marcos Paulo Veloso Correia, Sandra Torres, Thaís Zamprogno, Mario Newton Leitão de Azevedo, José Angelo de Souza Papi, Lucio Souza Gonçalves, Arley Silva Junior |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Saliva Arthritis Disease Gastroenterology Xerostomia Statistics Nonparametric Salivary Glands Arthritis Rheumatoid Young Adult 03 medical and health sciences Sex Factors 0302 clinical medicine Surveys and Questionnaires Internal medicine medicine Humans General Materials Science 030212 general & internal medicine Young adult Aged Aged 80 and over business.industry Case-control study 030206 dentistry Middle Aged Dry mouth medicine.disease Temporomandibular joint Surgery lcsh:RK1-715 medicine.anatomical_structure lcsh:Dentistry Antirheumatic Agents Case-Control Studies Rheumatoid arthritis Female medicine.symptom Salivation Secretory Rate business |
| Zdroj: | Brazilian Oral Research, Volume: 30, Issue: 1, Article number: e106, Published: 10 OCT 2016 Brazilian Oral Research v.30 n.1 2016 Brazilian Oral Research Sociedade Brasileira de Pesquisa Odontológica (SBPqO) instacron:SBPQO Brazilian Oral Research, Vol 30, Iss 1 |
| Popis: | Oral complications of RA may include temporomandibular joint disorders, mucosa alterations and symptoms of dry mouth. The aim of this study was to evaluate the salivary gland function of subjects with rheumatoid arthritis (RA) comparing it to healthy controls. Subjects with other systemic conditions known to affect salivary functions were excluded. A questionnaire was applied for the evaluation of xerostomia. Resting and chewing-stimulated salivary flow rates (SFR) were obtained under standard conditions. There were 145 subjects included of the study (104 RA and 38 controls). About 66.7% of the RA subjects and 2.4% in control group presented xerostomia. The median resting SFR were 0.24 ml/min for RA subjects and 0.40 mL/min for controls (p = 0.04). The median stimulated SFR were 1.31 mL/min for RA subjects and 1.52 ml/min for controls (p = 0.33). No significant differences were found between resting and stimulated SFR of RA subjects not using xerogenic medications and controls. There was significantly higher number of subjects presenting hyposalivation in the RA group than among controls, even when subjects using xerogenic medications were eliminated from the analysis. In conclusion, hyposalivation and xerostomia were more frequent among RA subjects not using xerogenic medication than among controls, although there were no significant differences in the median SFR between groups. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|